Heska Corp HSKA Income Statement

Heska corp (HSKA)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenue:
Total revenue, net
123,804	122,661	122,958	122,676	124,192	127,446	129,423	128,804	132,547	129,341	132,842	135,936	132,496	130,083	120,300	114,904	108,849	104,597	99,161	92,932	91,938	89,837	89,018	84,808	80,153	78,339	73,288	72,599	72,609	72,805	69,857	70,559	69,735	70,065	72,195	69,694	0	0	0
Cost of revenue
68,450	68,212	68,867	67,455	68,318	70,808	71,687	72,309	74,188	71,080	75,101	78,030	76,837	76,191	70,223	66,948	63,278	60,384	57,141	54,192	54,418	54,122	52,941	49,642	49,044	47,707	45,656	45,647	42,629	41,704	39,567	40,168	39,923	40,878	43,008	41,487	0	0	0
Gross profit
55,354	54,449	54,091	55,221	55,874	56,638	57,736	56,495	58,359	58,261	57,741	57,906	55,659	53,892	50,077	47,956	45,571	44,213	42,020	38,740	37,520	35,715	36,077	35,166	31,109	30,632	27,632	26,952	29,980	31,101	30,290	30,391	29,812	29,187	29,187	28,207	0	0	0
Operating expenses:
Selling and marketing
28,025	27,678	26,821	26,327	25,556	24,663	23,616	23,216	23,265	23,225	23,505	23,180	22,573	22,092	21,962	21,645	21,498	21,339	20,618	20,161	19,674	19,159	19,287	19,162	19,248	19,428	18,873	18,663	18,576	18,339	17,904	17,276	16,095	15,167	15,195	15,098	0	0	0
Research and development
9,002	8,240	7,307	5,710	4,030	3,334	2,592	2,258	2,144	2,004	2,118	2,024	2,102	2,147	1,959	1,945	1,814	1,658	1,634	1,463	1,445	1,414	1,387	1,389	1,498	1,500	1,438	1,294	1,014	958	1,022	1,153	1,653	1,650	1,800	1,877	0	0	0
General and administrative
22,543	18,204	17,097	24,106	24,440	24,847	23,955	16,075	15,648	14,813	14,477	14,347	13,633	13,120	12,573	13,133	12,753	12,659	13,022	12,171	12,368	12,231	11,491	10,969	11,212	11,134	10,786	10,562	9,996	9,646	9,512	9,675	9,273	9,121	8,992	8,647	0	0	0
Total operating expenses
59,570	54,122	51,225	56,143	54,026	52,844	50,163	41,549	41,057	40,042	40,100	39,551	38,308	37,359	36,494	36,723	36,065	35,656	35,274	33,795	33,487	32,804	32,165	31,520	31,958	32,062	31,097	30,519	29,586	28,943	28,438	28,104	27,021	25,938	25,987	25,622	0	0	0
Operating Income (Loss)
-4,216	327	2,866	-922	1,848	3,794	7,573	14,946	17,302	18,219	17,641	18,355	17,351	16,533	13,583	11,233	9,506	8,557	6,746	4,945	4,033	2,911	3,912	3,646	-849	-1,430	-3,465	-3,567	394	2,158	1,852	2,287	2,791	3,249	3,200	2,585	0	0	0
Nonoperating Income (Expense)
695	2,910	-907	70	-1	-13	-374	-418	-208	-150	130	110	-42	29	320	403	400	130	-113	-222	-192	-39	-202	-69	-10	-37	200	91	-18	135	-149	-197	2	-117	-17	169	0	0	0
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest
-9,341	-2,583	1,985	-826	1,873	3,807	7,499	14,828	17,394	18,369	17,713	18,407	17,251	16,504	13,643	11,376	9,646	8,427	6,649	4,819	3,951	2,950	4,114	3,715	-839	-1,393	-3,665	-3,658	412	2,023	2,001	2,484	2,789	3,366	3,217	2,416	0	0	0
Income tax (benefit) expense:
Current income tax expense
339	359	197	184	168	140	80	61	59	49	148	263	340	407	1,633	1,616	1,611	1,581	166	120	70	47	225	171	198	183	187	197	172	214	106	120	139	165	120	104	0	0	0
Deferred Income Tax Expense (Benefit)
-2,283	-1,805	-2,338	-3,670	-3,013	-2,255	6,106	8,701	10,027	8,864	2,407	2,726	1,890	3,932	2,103	1,813	1,652	1,327	2,260	1,844	1,426	1,304	1,471	1,159	-177	-637	-1,404	-1,393	-27	606	597	746	837	1,056	1,195	863	0	0	0
Income Tax Expense (Benefit)
-1,944	-1,446	-2,126	-3,471	-2,830	-2,100	6,186	8,762	10,086	8,913	2,516	2,950	2,191	4,300	3,736	3,429	3,263	2,908	2,426	1,964	1,496	1,351	1,696	1,330	21	-454	-1,217	-1,196	145	820	703	866	976	1,221	1,315	967	0	0	0
Net (loss) income before equity in losses of unconsolidated affiliates
-7,991	-1,731	4,054	2,588	4,646	5,850	1,313	6,066	7,308	9,456	15,158	15,418	15,021	12,165	9,907	7,947	6,383	5,519	4,223	2,855	2,455	1,599	2,418	2,385	-860	-939	-2,448	-2,462	267	1,203	0	0	0	-	-	-	0	-	-
Equity in losses of unconsolidated affiliates
0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income (Loss) Attributable Before Nonredeemable Noncontrolling Interest Income
0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to redeemable non-controlling interest
-373	-266	-132	-91	-44	0	1	1	-193	-497	682	678	1,092	1,657	823	795	556	280	184	-282	-554	-1,004	-533	-294	-242	257	-464	-205	34	0	0	0	0	-	-	-	-	-	-
Net Income (Loss) Attributable to Parent
-7,567	-1,465	3,731	2,371	4,509	5,850	1,312	6,065	7,501	9,953	14,476	14,740	13,929	10,508	9,084	7,152	5,827	5,239	4,039	3,137	3,009	2,603	2,951	2,679	-618	-1,196	-1,984	-2,257	233	1,203	1,102	1,591	0	-	0	0	-	0	0
Earnings Per Share [Abstract]
Basic (loss) earnings per share attributable to Heska Corporation (in dollars per share)
-0.70	-0.24	-0.04	-0.03	0.11	0.48	-0.23	0.26	0.30	-0.14	0.43	0.47	0.66	0.50	0.49	0.38	0.18	0.29	0.22	0.19	0.10	0.14	0.09	0.18	0.03	0.20	0.04	-0.38	-0.07	0.08	-0.01	0.05	0.11	0.08	0.06	0.09	0.18	0.05	-0.03
Diluted (loss) earnings per share attributable to Heska Corporation (in dollars per share)
-0.70	-0.23	-0.04	-0.03	0.10	0.45	-0.23	0.24	0.28	-0.15	0.40	0.44	0.61	0.46	0.45	0.35	0.17	0.28	0.20	0.17	0.09	0.13	0.08	0.17	0.03	0.20	0.04	-0.38	-0.07	0.07	-0.01	0.05	0.11	0.09	0.05	0.09	0.17	0.05	-0.03
Weighted Average Number of Shares Outstanding, Basic
7,568	7,338	7,501	7,486	7,459	7,263	7,289	7,226	7,102	6,885	7,139	7,069	7,011	7,070	6,871	6,695	6,496	7,228	6,344	6,283	6,181	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average outstanding shares used to compute basic net income per share attributable to Heska Corp.
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	5	5	-	5	5	5	5	5	5	5	-15,684	5,239	5,234	5,232	5,224	5,217
Weighted Average Number of Shares Outstanding, Diluted
7,568	6,832	7,501	7,486	7,965	8,574	7,289	7,850	7,711	7,674	7,668	7,632	7,594	7,577	7,454	7,249	7,164	7,213	7,139	7,075	6,869	25,617	6	6	5	23,002	5	5	5	5	5	5	5	-16,003	5,411	5,353	5,261	5,238	5,217
Core companion animal
Total revenue, net
109,160	106,570	104,042	104,893	106,821	108,924	110,392	108,780	108,226	105,191	108,566	109,374	107,748	107,398	97,221	91,818	88,111	84,249	82,443	77,831	74,560	72,354	71,612	69,756	68,121	66,404	61,706	60,721	60,571	61,502	58,565	59,298	57,620	57,481	58,871	58,339	0	0	0
Other vaccines and pharmaceuticals
Total revenue, net
14,644	16,091	18,916	17,783	17,371	18,522	19,031	20,024	24,321	24,150	24,276	26,562	24,748	22,685	23,079	23,086	20,738	20,348	16,718	15,101	17,378	17,483	17,406	15,052	12,032	11,935	11,582	11,878	12,038	11,303	11,292	11,261	12,115	12,584	13,324	11,355	0	0	0